Erasmus University Rotterdam
Also known as: Annelies Verbon | CUB Erasme Hospital ULB | CUB-Hôpital Erasme | Daniel Den Hoed Cancer Center at Erasmus Medical Center | Department of Gastroeneterology and Hepatology, Erasmus University Medical Center | Department of Internal Medicine - Endocrinology, Erasmus MC, Rotterdam, the Netherlands | Dept. Neurology, Erasmus MC | Dept. of Gastroenterology & Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands | EMC | EMC Rotterdam | Eramus University Medical Centre | Erasme | ERASME | Erasme-CUB | Erasme hospital | Erasme Hospital | Erasme Hospital Brussels | Erasme Hospital, Bruxelles, Belgium | Erasme Hospital - Laboratoire de recherche en reproduction humaine | Erasme University Hospital | Erasme University Hospital, Brussels, Belgium | Erasmus Hospital Bruxelles | Erasmus MC | Erasmus MC Cancer Institute | Erasmus MC Cancer Institute, Rotterdam | Erasmus MC, Center for Pain Medicine | Erasmus MC, dermatology department | Erasmus MC / HOVON | Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands | Erasmus MC, Rotterdam | Erasmus MC Rotterdam Anesthesiology | Erasmus MC, Rotterdam / HollandPTC, Delft - The Netherlands | Erasmus MC, Rotterdam, Netherlands | Erasmus MC, Rotterdam, the Netherlands | Erasmus MC - Sophia Children's Hospital | Erasmus MC-Sophia Children's Hospital | Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands | Erasmus MC University Hospital | Erasmus MC University Medical Center | Erasmus MC University Medical Center Rotterdam | Erasmus MC, University Medical Center Rotterdam | Erasmus Medical Center | Erasmus Medical Center Cancer Institure | Erasmus Medical Center, Department of Intensive Care | Erasmus Medical Center; Department of Medical Oncology | Erasmus Medical Center, Rotterdam | Erasmus Medical Center, Rotterdam, Netherlands | Erasmus Medical Center - Sophia Children's Hospital | Erasmus Medical Centre | Erasmus Medical Centre Cancer Institute | Erasmus Medical Centre, Rotterdam | Erasmus Medical Centrum Rotterdam, NL | Erasmus Medisch Centrum | Erasmus University college Brussels | Erasmus University Medical Center (Netherlands) | Erasmus University Medical Center, Netherlands | Erasmus University Medical Center Rotterdam | Erasmus University Medical Center, Rotterdam, Netherlands | Erasmus University Medical Center Rotterdam, The Netherlands | Erasmus University Medical Centrum, ThoraxCenter | Erasmus University Rotterdam | Erasmus University Rotterdam (Katrien Helmerhorst) | Erasmus University Study Center | Fonds Erasme | Foundation for Liver Research (SLO) and Erasmus Medical Center | Hôpital Erasme | K.R. van Straalen | M.B.A. van Doorn | Sophia Children's Hospital, Erasmus MC | Sophia Children's Hospital Erasmus MC Rotterdam | Sophia Children's Hospital, Erasmus MC Rotterdam | Thorax Centre Erasmus MC, Rotterdam, the Netherlands | Thorax Centrum, Erasmus Medisch Centrum, s-Grave dijkwal 230, 3015 CE Rotterdam, the Netherlands | University Medical Center Rotterdam at Erasmus Medical Center
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1994Last known activity
Oct 31, 2025
Timeline
1910s
- Jan 1, 1913
Erasmus University Rotterdam— Founded
Drugs by trial phase (371 distinct, 365 trials)
Phase 4 (102 own, 0 via acquisition)
Phase 3 (129 own, 0 via acquisition)
Phase 2 (83 own, 0 via acquisition)
Phase 1 (21 own, 0 via acquisition)
Other trials (36 own, 0 via acquisition)
Indications
Studied for
- Acne Keloid
- Acquired Immunodeficiency Syndrome
- Acromegaly
- Adenocarcinoma
- Adenoviridae Infections
- Aggression
- Anemia, Refractory, with Excess of Blasts
- Anemia, Sickle Cell
- Aortic Valve Stenosis
- Arteriosclerosis
- Arthritis
- Arthritis, Juvenile
- Aspergillosis
- Asthma
- Autistic Disorder
- Bacterial Infections
- Basal Cell Carcinoma
- Biliary Tract Diseases
- Blast Crisis
- Brain Diseases
- Brain Neoplasms
- Breast Neoplasms
- Bronchiectasis
- Bronchopulmonary Dysplasia
- Cancer Pain
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Central Nervous System Neoplasms
- Cerebral Infarction
- Cervical Intraepithelial Neoplasia
- Cholangiocarcinoma
- Cholangitis
- Cholangitis, Sclerosing
- Chronic Pain
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Condylomata Acuminata
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Cystic Fibrosis
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diarrhea
- Drug Hypersensitivity
- Edema
- Endometrial Neoplasms
- Endophthalmitis
- End Stage Liver Disease
- Erectile Dysfunction
- Esophageal Atresia
- Essential Hypertension
- Exocrine Pancreatic Insufficiency
- Fallopian Tube Neoplasms
- Fatigue
- Femur Head Necrosis
- Fibrosis
- Fistula
- Gastroesophageal Reflux
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Heart Arrest
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Hematologic Diseases
- Hepatic Encephalopathy
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hernia
- Hernia, Diaphragmatic
- Hidradenitis
- Hidradenitis Suppurativa
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- HIV Infections
Recent trials (50)
- NCT06932562OfficialPhase 3Oct 31, 2025
- NCT06957782Lead sponsorN/ASep 30, 2025
- NCT06957782Sponsor investigatorN/ASep 30, 2025
- NCT06957782OfficialN/ASep 30, 2025
- NCT07145736CollaboratorPhase 4Aug 4, 2025
- NCT06823479CollaboratorPhase 2May 14, 2025
- NCT06923475CollaboratorPhase 2/Phase 3May 5, 2025
- NCT06859957Sponsor investigatorPhase 3Mar 19, 2025
- NCT06859957Lead sponsorPhase 3Mar 19, 2025
- NCT06771492Sponsor investigatorPhase 3Feb 28, 2025
- NCT06771492CollaboratorPhase 3Feb 28, 2025
- NCT06771492Lead sponsorPhase 3Feb 28, 2025
- NCT06785974Lead sponsorPhase 4Feb 28, 2025
- NCT06785974Sponsor investigatorPhase 4Feb 28, 2025
- NCT06714838CollaboratorPhase 3Oct 16, 2024
Details
- Founded
- Rotterdam, NL Jan 1, 1913
- Last known activity
- Oct 31, 2025